Bryan D Choi1, Peter E Fecci2, John H Sampson2,3,4. 1. Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; 2. Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery; 3. Departments of Pathology and Radiation Oncology; and. 4. The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, North Carolina.
Authors: Jeffrey Braithwaite; Jessica Herkes; Kate Churruca; Janet C Long; Chiara Pomare; Claire Boyling; Mia Bierbaum; Robyn Clay-Williams; Frances Rapport; Patti Shih; Anne Hogden; Louise A Ellis; Kristiana Ludlow; Elizabeth Austin; Rebecca Seah; Elise McPherson; Peter D Hibbert; Johanna Westbrook Journal: BMJ Open Date: 2019-03-30 Impact factor: 2.692